BioCentury
ARTICLE | Company News

Cytogen, Schering deal

May 15, 2006 7:00 AM UTC

CYTO paid SCH's Berlex Laboratories Inc. (Montville, N.J.) $6 million in cash and issued 623,441 shares to eliminate the royalty that Berlex receives on sales of CYTO's Quadramet, which is approved f...